Dave Inc. (NASDAQ: DAVE ) is a financial technology company that offers banking services, personal finance tools, cash advance features, and many other solutions. The company is largely known for being a leading neobank and operating on a digital-first platform (mobile app) with noAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against four companies: Dave, Inc., Red Cat Holdings, Inc., Perpetua Resources Corp., and Voyager Therapeutics, Inc. for possible violations of federal securities laws and other unlawful business practices [1] Company Summaries Dave, Inc. (NASDAQ: DAVE) - The Justice Department and FTC announced a civil enforcement action against Dave, Inc. and its CEO Jason Wilk for alleged violations of the FTC Act and ROSCA, claiming misleading advertising regarding cash advances, hidden fees, and recurring monthly fees without a cancellation mechanism [2] - Following the announcement, Dave shares opened at $84.00 on December 31, 2024, reflecting a drop of over 10% from the previous day [3] Red Cat Holdings, Inc. (NASDAQ: RCAT) - Kerrisdale Capital published a report alleging that Red Cat overstated the revenue potential of its U.S. Army SRR drone contract and lacks the production capacity to fulfill its promises, raising concerns about executive departures and insider transactions [4] - As a result, Red Cat's stock price fell by $2.36 per share, or 21.63%, closing at $8.55 per share on January 17, 2025 [4] Perpetua Resources Corp. (NASDAQ: PPTA) - The investigation focuses on whether Perpetua issued false or misleading statements and failed to disclose pertinent information. The company released an updated cash flow model for the Stibnite Gold Project, indicating increased capital expenditures and costs, but improved economic metrics due to rising commodity prices [5] - Following this news, shares of Perpetua fell by 22.3% on February 14, 2025 [5] Voyager Therapeutics, Inc. (NASDAQ: VYGR) - Voyager announced it would assess alternate payloads for its gene therapy program for ALS, stating that emerging preclinical data indicated issues with the siRNA payload component of VY9323, which does not meet their standards [6] - Consequently, Voyager's stock price dropped by $1.11 per share, or 20.86%, closing at $4.21 per share on February 11, 2025 [6]

One stock that might be an intriguing choice for investors right now is Dave Inc. (DAVE) . This is because this security in the Technology Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Technology Se ...

DALLAS, March 18, 2025 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today announced that it will report financial results for its fourth quarter and fiscal year ended February 4, 2025 after the market closes on Monday, April 7, 2025. Management will host a conference call to discuss these results on Monday, April 7, 2025, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time). A live and ar ...

Core Insights - NeuroOne Medical Technologies Corporation is focused on improving surgical care for patients with neurological disorders, particularly epilepsy, through innovative technology [1][5] - The company’s OneRF® Ablation System is the first FDA 510(k)-cleared device that can record brain activity and perform RF ablation simultaneously, representing a significant advancement in epilepsy treatment [3][4] Industry Overview - Over 50 million people globally are affected by epilepsy, with nearly one-third experiencing seizures that do not respond to medication, highlighting a substantial need for alternative treatment options [2] - Radiofrequency (RF) ablation therapy is emerging as a promising solution for patients who do not respond to traditional medication [2] Company Technology - The OneRF® system consists of three main components: an electrode for stimulation and monitoring, a temperature probe, and a radio frequency heat generator [3] - The system aims to improve patient outcomes by combining real-time monitoring with targeted ablation in a single procedure, potentially reducing the need for multiple invasive surgeries [4] Future Applications - NeuroOne is also exploring the potential of its technology for applications beyond epilepsy, including pain management and other neurological disorders such as Parkinson's disease and chronic pain [5]

Core Insights - NeuroOne Medical Technologies Corporation is focused on improving surgical care for patients with neurological disorders, particularly epilepsy, through innovative technology [1][5] - The OneRF® Ablation System is a significant advancement in epilepsy treatment, being the first FDA 510(k)-cleared device that can record brain activity and perform RF ablation simultaneously [3][4] Industry Overview - Over 50 million people globally are affected by epilepsy, with nearly one-third experiencing medication-resistant seizures, highlighting the need for alternative treatment options like RF ablation therapy [2] - The medical technology sector is increasingly focusing on minimally invasive solutions for neurological disorders, which may lead to improved patient outcomes and reduced procedural costs [5] Company Developments - The OneRF® system includes an electrode for brain activity monitoring, a temperature probe, and a radio frequency heat generator, enhancing the efficiency and precision of epilepsy treatments [3][4] - NeuroOne is also exploring the potential applications of its technology in pain management and other neurological conditions, indicating a broader market strategy [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Dave Inc. due to allegations of misleading business information [1] Group 1: Legal Actions and Allegations - The Justice Department and the Federal Trade Commission (FTC) announced a civil enforcement action against Dave Inc. and its CEO Jason Wilk for alleged violations of the FTC Act and the Restore Online Shoppers' Confidence Act [3] - The lawsuit claims that Dave misled consumers through deceptive advertising of cash advances, hidden fees, misrepresentation of customer tips usage, and recurring monthly fees without a simple cancellation mechanism [3] Group 2: Market Reaction - Following the announcement of the lawsuit, Dave's share price fell by 8% on December 31, 2024 [4] Group 3: Class Action Information - Investors who purchased Dave securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Interested investors can join the class action by visiting the provided link or contacting the Rosen Law Firm directly [2] Group 4: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [5] - The firm was ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions of dollars for investors over the years [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Dave Inc. due to allegations of misleading business information issued by the company [1] Group 1: Legal Actions and Allegations - The Justice Department and the Federal Trade Commission announced a civil enforcement action against Dave Inc. and its CEO Jason Wilk for alleged violations of the FTC Act and the Restore Online Shoppers' Confidence Act [3] - The lawsuit claims that Dave misled consumers through deceptive advertising of cash advances, hidden fees, misrepresentation of customer tips usage, and recurring monthly fees without an easy cancellation mechanism [3] Group 2: Market Reaction - Following the announcement of the lawsuit, Dave's share price fell by 8% on December 31, 2024 [4] Group 3: Class Action Information - Investors who purchased Dave securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Interested investors can join the class action by submitting a form or contacting the Rosen Law Firm directly [2] Group 4: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and being ranked highly in the field since 2013 [5] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering investor losses [5]

Core Points - Dave & Buster's has launched the UFC Challenge game, enhancing its partnership with UFC and aiming to elevate the fight-night experience for fans [1][4][11] - The game is available at all Dave & Buster's locations nationwide, designed to provide an immersive and interactive experience for UFC fans [2][5][6] Company Overview - Dave & Buster's operates 232 venues across North America, offering a combination of dining and entertainment experiences [12] - The company features a full menu and a variety of entertainment attractions, including arcade games and live sports viewing [12] UFC Partnership - The partnership with UFC, first announced in 2022, has positioned Dave & Buster's as a premier venue for UFC events, showcasing fights on over 30 HD TVs [4][11] - The UFC Challenge game was developed in collaboration with multiple partners, including Rider & IGPM Distribution and Adrenaline Amusements [5][11] Game Features - The UFC Challenge game is a large, interactive arcade game that tests players' speed, accuracy, and endurance, standing 12 feet tall and weighing 1,700 pounds [5] - It includes single-player and two-player modes, allowing fans to engage in competitive gameplay with authentic UFC branding and visuals [8] Upcoming Events - Dave & Buster's will host UFC Pay-Per-View events and Fight Nights, ensuring fans have an optimal viewing experience [7][9]

Los Angeles, March 10, 2025 (GLOBE NEWSWIRE) -- Dave Inc. (“Dave” or the “Company”) (NASDAQ: DAVE), one of the nation’s leading neobanks, today announced that its Board of Directors has authorized a share repurchase program to buy back up to $50 million of its outstanding Class A common stock. The repurchase program does not have a fixed expiration date and may be executed from time to time based on market conditions, liquidity, and other strategic considerations. Subject to market conditions, the Company e ...